Dr. Forst is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
# 9E
Boston, MA 02114Phone+1 617-724-8770Fax+1 617-724-8669
Education & Training
- Massachusetts General HospitalFellowship, Neuro-Oncology, 2014 - 2017
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2011 - 2014
- Baylor College of MedicineInternship, Internal Medicine, 2010 - 2011
- Baylor College of MedicineClass of 2010
Certifications & Licensure
- MA State Medical License 2014 - 2026
- ME State Medical License 2023 - 2026
- NH State Medical License 2023 - 2025
- VT State Medical License 2023 - 2024
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer Start of enrollment: 2018 Apr 02
- Psychological Intervention for Caregivers of Patients With Malignant Gliomas Start of enrollment: 2019 Feb 08
- NeuroPathways Intervention for Brain Tumor Patients Start of enrollment: 2023 Oct 16
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 20 citationsPalliative care and end-of-life care in adults with malignant brain tumors.Johan A F Koekkoek, Pim B van der Meer, Andrea Pace, Caroline Hertler, Rebecca Harrison
Neuro-Oncology. 2023-03-14 - 133 citationsFirst-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysisBenjamin Kasenda, Andrés José Maria Ferreri, E. Marturano, Deborah Forst, Jacoline E C Bromberg
Annals of Oncology. 2015-07-01 - 80 citationsSingle-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K. Brastianos, Eudocia Q. Lee, Justine V. Cohen, Sara M. Tolaney, Nan Lin
Nature Medicine. 2020-08-01
Press Mentions
- Rapid Test of Cerebrospinal Fluid Decreases Time to Diagnosis for Brain TumorsJune 18th, 2024
- Rapid Test of Cerebrospinal Fluid Found to Decrease Time to Diagnosis for Brain TumorsJune 19th, 2024
Professional Memberships
- Member
- Member
- Member
- Member
- Society for Neuro-Oncology (SNO)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: